DENTSPLY SIRONA Inc. (NASDAQ:XRAY) to Post Q1 2023 Earnings of $0.31 Per Share, Zacks Research Forecasts

DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Rating) – Analysts at Zacks Research boosted their Q1 2023 earnings per share (EPS) estimates for shares of DENTSPLY SIRONA in a research note issued to investors on Tuesday, March 14th. Zacks Research analyst I. Bandyopadhyay now forecasts that the medical instruments supplier will post earnings per share of $0.31 for the quarter, up from their previous forecast of $0.29. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.87 per share. Zacks Research also issued estimates for DENTSPLY SIRONA’s Q2 2023 earnings at $0.44 EPS, Q3 2023 earnings at $0.50 EPS, Q4 2023 earnings at $0.58 EPS, FY2023 earnings at $1.83 EPS, Q1 2024 earnings at $0.43 EPS, Q2 2024 earnings at $0.48 EPS, Q3 2024 earnings at $0.51 EPS, Q4 2024 earnings at $0.65 EPS, FY2024 earnings at $2.07 EPS and FY2025 earnings at $2.40 EPS.

A number of other equities analysts have also commented on XRAY. Piper Sandler boosted their price objective on DENTSPLY SIRONA from $29.00 to $35.00 and gave the stock a “neutral” rating in a research note on Monday, February 6th. TheStreet upgraded shares of DENTSPLY SIRONA from a “d+” rating to a “c” rating in a research report on Tuesday, February 28th. The Goldman Sachs Group raised their price objective on shares of DENTSPLY SIRONA from $34.00 to $39.00 and gave the company a “neutral” rating in a research report on Wednesday, March 1st. William Blair upgraded shares of DENTSPLY SIRONA from an “underperform” rating to a “market perform” rating in a research report on Wednesday, January 11th. Finally, started coverage on shares of DENTSPLY SIRONA in a research note on Thursday. They set a “hold” rating on the stock. Seven research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to, the company has an average rating of “Hold” and an average price target of $39.33.


NASDAQ XRAY opened at $37.44 on Thursday. The stock’s 50 day simple moving average is $36.72 and its 200 day simple moving average is $32.76. DENTSPLY SIRONA has a one year low of $26.48 and a one year high of $50.64. The firm has a market cap of $8.06 billion, a PE ratio of 14.06, a price-to-earnings-growth ratio of 2.26 and a beta of 0.92. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.08.

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) last issued its quarterly earnings data on Tuesday, February 28th. The medical instruments supplier reported $0.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.32 by $0.14. The company had revenue of $983.00 million during the quarter, compared to analysts’ expectations of $939.11 million. DENTSPLY SIRONA had a positive return on equity of 8.71% and a negative net margin of 24.35%. The business’s revenue was down 10.9% on a year-over-year basis. During the same period last year, the business earned $0.76 earnings per share.

Hedge Funds Weigh In On DENTSPLY SIRONA

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Wipfli Financial Advisors LLC acquired a new stake in shares of DENTSPLY SIRONA in the 3rd quarter valued at approximately $27,000. Quadrant Capital Group LLC increased its stake in DENTSPLY SIRONA by 311.2% in the fourth quarter. Quadrant Capital Group LLC now owns 847 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 641 shares in the last quarter. Riverview Trust Co raised its holdings in DENTSPLY SIRONA by 185.6% in the third quarter. Riverview Trust Co now owns 991 shares of the medical instruments supplier’s stock worth $28,000 after purchasing an additional 644 shares during the period. SRS Capital Advisors Inc. bought a new position in shares of DENTSPLY SIRONA during the third quarter worth $28,000. Finally, Ellevest Inc. grew its holdings in shares of DENTSPLY SIRONA by 281.2% in the 3rd quarter. Ellevest Inc. now owns 1,216 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 897 shares during the period. Institutional investors own 98.52% of the company’s stock.

Insider Buying and Selling

In other news, SVP Cord Friedrich Staehler sold 4,000 shares of the stock in a transaction on Tuesday, March 7th. The stock was sold at an average price of $39.33, for a total value of $157,320.00. Following the transaction, the senior vice president now owns 97,693 shares of the company’s stock, valued at approximately $3,842,265.69. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.76% of the stock is currently owned by insiders.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 14th. Investors of record on Friday, March 31st will be paid a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.34%. The ex-dividend date is Thursday, March 30th.


(Get Rating)

Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.

Read More

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with's FREE daily email newsletter.